Related references
Note: Only part of the references are listed.Clinical characteristics of bacteremia caused by Haemophilus and Aggregatibacter species and antimicrobial susceptibilities of the isolates
Ying-Chun Chien et al.
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION (2021)
Rescue therapy with rifabutin regimen for refractory Helicobacter pylori infection with dual drug-resistant strains
Chia-Jung Kuo et al.
BMC GASTROENTEROLOGY (2020)
Primary and secondary antibiotic resistance of Helicobacter pylori in Korea from 2003 to 2018
Ju Yup Lee et al.
HELICOBACTER (2019)
Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report
P. Malfertheiner et al.
GUT (2017)
Cholesterol glucosylation by Helicobacter pylori delays internalization and arrests phagosome maturation in macrophages
Shin-Yi Du et al.
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION (2016)
High-dose Dual Therapy Is Superior to Standard First-line or Rescue Therapy for Helicobacter pylori Infection
Jyh-Chin Yang et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2015)
Comparative in vitro antimicrobial susceptibility and synergistic activity of antimicrobial combinations against Helicobacter pylori isolates in Taiwan
Aristine Cheng et al.
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION (2015)
Efficacy of genotypic resistance-guided sequential therapy in the third-line treatment of refractory Helicobacter pylori infection: a multicentre clinical trial
Jyh-Ming Liou et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2013)
Helicobacter pylori Infection
Kenneth E. L. McColl
NEW ENGLAND JOURNAL OF MEDICINE (2010)